Posts tagged ‘oncology’

The field of preclinical oncology research is being hit by a new wave of innovation, specifically innovation in disease model sourcing for drug...

This installment was written by Discovery Life Sciences, the Biospecimen and Biomarker Specialists™. Discovery’s Global Tissue Biomarker Services...

This installment of Supplier Spotlight® is on SciQuus Oncology – an oncology-focused clinical research organization committed to the advancement of...

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...

This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...

This month Drug Discovery News published Dr. Kevin Lustig’s editorial discussing how outsourcing is a viable strategy for advancing oncology...

An oncogene is a gene that can potentially cause cancer. RAS is a common class of oncogene and the focus of researchers worldwide, particularly at...

As previously discussed, there is great value in using in vivo models such as genetically modified mice and xenograft models for oncology research...

Xenograft is animal tissue implanted into a different species and is often used for evaluating treatment for disease and organ failure. Currently...